+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Circulating Tumor CellDetection Market - Global Forecast 2025-2030- Product Image
Circulating Tumor CellDetection Market - Global Forecast 2025-2030- Product Image
Sale

Circulating Tumor CellDetection Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6122760
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Circulating tumor cell detection is reshaping cancer diagnostics with rapid advances in liquid biopsy technology. Senior decision-makers now face a complex yet opportunity-rich market where innovation, regulatory change, global supply pressures, and clinical urgency intersect—requiring informed strategies to stay competitive.

Circulating Tumor Cell Detection Market Snapshot

The circulating tumor cell detection market is driven by a shift from traditional, research-focused tools to mainstream solutions that support personalized oncology. Market growth is propelled by the adoption of microfluidic and immunoaffinity platforms, rising demand for minimally invasive diagnostics, and supportive infrastructure, especially in North America and key Asia-Pacific economies. Strategic investments in R&D, combined with tariff developments and evolving clinical guidelines, are influencing cost structures, technology adoption, and market entry decisions across regions.

Scope & Segmentation

This research comprehensively covers the global landscape for circulating tumor cell detection. The segmentation ensures stakeholders receive strategic visibility across diverse applications and regional dynamics. Taxonomy includes:

  • Technology: Dielectrophoresis (Electrode-Based, Insulator-Based), Immunoaffinity (Negative Selection, Positive Selection), Microfluidics (Active, Passive), Size-Based Filtration (Membrane Filtration, Microfilter Chips)
  • Sample Types: Blood (Plasma Enriched, Whole Blood), Bone Marrow (Aspirate, Biopsy), Pleural Effusion (Fluid Separation)
  • Applications: Cancer Research (Molecular Analysis, Single-Cell Sequencing), Early-Stage Detection (Minimal Residual Disease, Screening), Prognosis and Monitoring (Prognostic Assessment, Therapeutic Monitoring)
  • End Users: Diagnostic Laboratories, Hospitals, Pharmaceutical Companies, Research Institutes
  • Geographic Regions: Americas (United States including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (including UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: Menarini Silicon Biosystems S.p.A., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., RareCyte, Inc., BioView Ltd., Epic Sciences, Inc., ScreenCell SA, NanoCellect Biomedical, Inc., Cynvenio Biosystems, Inc.

Key Takeaways for Senior Decision-Makers

  • Rapid advances in microfluidic and immunoaffinity technologies are facilitating the detection and molecular analysis of rare circulating cells, supporting precision oncology and non-invasive disease monitoring.
  • Regulatory frameworks have been updated worldwide to accelerate liquid biopsy approvals, offering market entrants faster access to patient populations while maintaining safety and efficacy standards.
  • Strategic academic-industry collaborations and translational research networks are enhancing portfolio development and enabling validation of new biomarkers, a critical step for commercial differentiation.
  • Regional dynamics impact technology adoption; for example, government-backed programs in Asia-Pacific are expanding genomic infrastructure, whereas North America benefits from established reimbursement models.
  • Turnkey bundled solutions that integrate instruments, consumables, and services are emerging as a preferred customer offering, promoting loyalty and streamlining purchasing for laboratories and clinics.

Tariff Impact on Circulating Tumor Cell Detection Supply Chains

United States tariff adjustments in 2025 have increased the cost of instrument components and raw materials, prompting companies to assess alternate vendors and regionalize production. Extended lead times and customs complexities are driving industry-wide adoption of lean inventory management and cost-buffering supply chain strategies. These measures help sustain assay pricing and innovation momentum, but ongoing public–private engagement seeks to reduce trade barriers for life sciences diagnostics.

Methodology & Data Sources

The analysis utilizes a multi-tiered approach, integrating interviews with clinical, regulatory, and industry experts alongside systematic review of peer-reviewed articles, trade reports, and regulatory filings. Findings are validated via cross-referencing multiple independent sources and informed by SWOT and PESTEL frameworks for market robustness.

Why This Circulating Tumor Cell Detection Report Matters

  • Delivers actionable insights for management teams seeking to optimize market entry, technology selection, and partnership models in a rapidly evolving diagnostic domain.
  • Supports procurement, regulatory, and R&D leaders with clarity on how shifting tariffs, clinical guidelines, and technology platforms shape investment priorities and risk mitigation strategies.

Conclusion

Circulating tumor cell detection is advancing from niche technology to clinical mainstream. Informed, strategic decisions are essential for capitalizing on this progression and achieving sustained growth in precision oncology.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of microfluidics and nanomaterials for enhanced tumor cell isolation and viability preservation
5.2. Application of single-cell genomic sequencing to characterize heterogeneous circulating tumor cell populations in real time
5.3. Development of label-free optical detection platforms enabling high-throughput analysis of viable circulating tumor cells
5.4. Use of AI-based image analysis to automate identification and morphological profiling of individual circulating tumor cells
5.5. Implementation of liquid biopsy assays combining CTC enumeration with cell-free DNA profiling for comprehensive tumor monitoring
5.6. Advancement of epigenetic biomarker detection in circulating tumor cells to inform personalized treatment decisions
5.7. Commercial launch of fully automated benchtop systems for standardized circulating tumor cell capture and downstream analysis
5.8. Clinical validation of CTC dynamics as predictive biomarkers for immunotherapy response in metastatic cancer patients
5.9. Research on integrating 3D in vitro tumor models with circulating tumor cells to study metastasis mechanisms
5.10. Collaborations between biotech firms and academic institutions to develop multiplexed microchip platforms for real-time CTC enumeration
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Circulating Tumor CellDetection Market, by Technology
8.1. Introduction
8.2. Dielectrophoresis
8.2.1. Electrode-Based
8.2.2. Insulator-Based
8.3. Immunoaffinity
8.3.1. Negative Selection
8.3.2. Positive Selection
8.4. Microfluidics
8.4.1. Active Microfluidics
8.4.2. Passive Microfluidics
8.5. Size-Based Filtration
8.5.1. Membrane Filtration
8.5.2. Microfilter Chips
9. Circulating Tumor CellDetection Market, by Sample Type
9.1. Introduction
9.2. Blood
9.2.1. Plasma Enriched
9.2.2. Whole Blood
9.3. Bone Marrow
9.3.1. Aspirate
9.3.2. Biopsy
9.4. Pleural Effusion
9.4.1. Fluid Separation
10. Circulating Tumor CellDetection Market, by Application
10.1. Introduction
10.2. Cancer Research
10.2.1. Molecular Analysis
10.2.2. Single-Cell Sequencing
10.3. Early-Stage Detection
10.3.1. Minimal Residual Disease
10.3.2. Screening
10.4. Prognosis and Monitoring
10.4.1. Prognostic Assessment
10.4.2. Therapeutic Monitoring
11. Circulating Tumor CellDetection Market, by End User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Hospitals
11.4. Pharmaceutical Companies
11.5. Research Institutes
12. Americas Circulating Tumor CellDetection Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Circulating Tumor CellDetection Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Circulating Tumor CellDetection Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Menarini Silicon Biosystems S.p.A.
15.3.2. Bio-Rad Laboratories, Inc.
15.3.3. Thermo Fisher Scientific Inc.
15.3.4. QIAGEN N.V.
15.3.5. RareCyte, Inc.
15.3.6. BioView Ltd.
15.3.7. Epic Sciences, Inc.
15.3.8. ScreenCell SA
15.3.9. NanoCellect Biomedical, Inc.
15.3.10. Cynvenio Biosystems, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CIRCULATING TUMOR CELLDETECTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CIRCULATING TUMOR CELLDETECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CIRCULATING TUMOR CELLDETECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CIRCULATING TUMOR CELLDETECTION MARKET: RESEARCHAI
FIGURE 24. CIRCULATING TUMOR CELLDETECTION MARKET: RESEARCHSTATISTICS
FIGURE 25. CIRCULATING TUMOR CELLDETECTION MARKET: RESEARCHCONTACTS
FIGURE 26. CIRCULATING TUMOR CELLDETECTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CIRCULATING TUMOR CELLDETECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY ELECTRODE-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY ELECTRODE-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY INSULATOR-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY INSULATOR-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY NEGATIVE SELECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY NEGATIVE SELECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY POSITIVE SELECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY POSITIVE SELECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY ACTIVE MICROFLUIDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY ACTIVE MICROFLUIDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PASSIVE MICROFLUIDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PASSIVE MICROFLUIDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MEMBRANE FILTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MEMBRANE FILTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFILTER CHIPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFILTER CHIPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLASMA ENRICHED, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLASMA ENRICHED, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY ASPIRATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY ASPIRATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY FLUID SEPARATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY FLUID SEPARATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MOLECULAR ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MOLECULAR ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SINGLE-CELL SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SINGLE-CELL SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY EARLY-STAGE DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY EARLY-STAGE DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MINIMAL RESIDUAL DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MINIMAL RESIDUAL DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY EARLY-STAGE DETECTION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY EARLY-STAGE DETECTION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSIS AND MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSIS AND MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSTIC ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSTIC ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSIS AND MONITORING, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSIS AND MONITORING, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY EARLY-STAGE DETECTION, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY EARLY-STAGE DETECTION, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSIS AND MONITORING, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSIS AND MONITORING, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY EARLY-STAGE DETECTION, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY EARLY-STAGE DETECTION, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSIS AND MONITORING, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSIS AND MONITORING, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 163. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, 2018-2024 (USD MILLION)
TABLE 166. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, 2025-2030 (USD MILLION)
TABLE 167. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, 2018-2024 (USD MILLION)
TABLE 168. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, 2025-2030 (USD MILLION)
TABLE 169. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 170. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 171. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, 2018-2024 (USD MILLION)
TABLE 172. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, 2025-2030 (USD MILLION)
TABLE 173. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 174. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 175. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 176. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 177. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 178. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 179. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, 2018-2024 (USD MILLION)
TABLE 180. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, 2025-2030 (USD MILLION)
TABLE 181. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
TABLE 184. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
TABLE 185. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY EARLY-STAGE DETECTION, 2018-2024 (USD MILLION)
TABLE 186. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY EARLY-STAGE DETECTION, 2025-2030 (USD MILLION)
TABLE 187. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSIS AND MONITORING, 2018-2024 (USD MILLION)
TABLE 188. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSIS AND MONITORING, 2025-2030 (USD MILLION)
TABLE 189. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. CANADA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 192. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 193. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, 2018-2024 (USD MILLION)
TABLE 194. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, 2025-2030 (USD MILLION)
TABLE 195. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, 2018-2024 (USD MILLION)
TABLE 196. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, 2025-2030 (USD MILLION)
TABLE 197. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 199. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, 2018-2024 (USD MILLION)
TABLE 200. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, 2025-2030 (USD MILLION)
TABLE 201. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 202. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 203. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 204. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 205. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 206. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 207. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, 2018-2024 (USD MILLION)
TABLE 208. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, 2025-2030 (USD MILLION)
TABLE 209. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
TABLE 212. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
TABLE 213. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY EARLY-STAGE DETECTION, 2018-2024 (USD MILLION)
TABLE 214. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY EARLY-STAGE DETECTION, 2025-2030 (USD MILLION)
TABLE 215. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSIS AND MONITORING, 2018-2024 (USD MILLION)
TABLE 216. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSIS AND MONITORING, 2025-2030 (USD MILLION)
TABLE 217. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. MEXICO CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY EARLY-STAGE DETECTION, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY EARLY-STAGE DETECTION, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSIS AND MONITORING, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSIS AND MONITORING, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY EARLY-STAGE DETECTION, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY EARLY-STAGE DETECTION, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSIS AND MONITORING, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PROGNOSIS AND MONITORING, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY DIELECTROPHORESIS, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY IMMUNOAFFINITY, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SIZE-BASED FILTRATION, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY PLEURAL EFFUSION, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELLDETECTION MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Circulating Tumor CellDetection market report include:
  • Menarini Silicon Biosystems S.p.A.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • RareCyte, Inc.
  • BioView Ltd.
  • Epic Sciences, Inc.
  • ScreenCell SA
  • NanoCellect Biomedical, Inc.
  • Cynvenio Biosystems, Inc.

Related Topics

Related Reports

Circulating Tumor Cell Market - Global Forecast 2025-2030 - Product Image

Circulating Tumor Cell Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Circulating Tumor Cells Market Size, Share & Trends Analysis Report By Application (Clinical, Research), By Specimen (Bone Marrow, Blood), By Product, By Technology, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Circulating Tumor Cells Market Size, Share & Trends Analysis Report By Application (Clinical, Research), By Specimen (Bone Marrow, Blood), By Product, By Technology, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2025-2033 - Product Image

Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2025-2033

  • Report
  • 137 Pages
  • Global
From
Circulating Tumor Cell (CTC) Diagnostics - Global Strategic Business Report - Product Image

Circulating Tumor Cell (CTC) Diagnostics - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Circulating Tumor Cells Market Report 2025 - Product Image

Circulating Tumor Cells Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.